Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Stockholder Note Receivable
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2020   145,196,000        
Balance at Dec. 31, 2020 $ 1,481,413 $ 1,452 $ 1,569,905 $ (15,000) $ (71,714) $ (3,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (229,157)       (229,157)  
Other comprehensive income 2,727         2,727
Share-based compensation 1,130   1,130      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 3,844   3,844      
Dividends on preferred stock (10,288)   (10,288)      
Balance (in shares) at Jun. 30, 2021   145,196,000        
Balance at Jun. 30, 2021 1,249,669 $ 1,452 1,564,591 (15,000) (300,871) (503)
Balance (in shares) at Mar. 31, 2021   145,196,000        
Balance at Mar. 31, 2021 1,325,492 $ 1,452 1,565,623 (15,000) (224,515) (2,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (76,356)       (76,356)  
Other comprehensive income 1,565         1,565
Share-based compensation 1,130   1,130      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 3,844   3,844      
Dividends on preferred stock (6,006)   (6,006)      
Balance (in shares) at Jun. 30, 2021   145,196,000        
Balance at Jun. 30, 2021 $ 1,249,669 $ 1,452 1,564,591 $ (15,000) (300,871) (503)
Balance (in shares) at Dec. 31, 2021 193,060,000 193,060,000        
Balance at Dec. 31, 2021 $ 2,091,392 $ 1,931 2,743,560   (651,083) (3,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (40,251)       (40,251)  
Other comprehensive income (1,324)         (1,324)
Share-based compensation $ 27,411   27,411      
Stock option exercises (in shares) 100,000 114,000        
Stock option exercises $ 1,194 $ 1 1,193      
Equity issuance costs (270)   (270)      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   622,000        
Issuance of common shares in connection with the vesting of restricted stock units 0 $ 6 (6)      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards $ 505   505      
Balance (in shares) at Jun. 30, 2022 193,796,000 193,796,000        
Balance at Jun. 30, 2022 $ 2,078,657 $ 1,938 2,772,393   (691,334) (4,340)
Balance (in shares) at Mar. 31, 2022   193,060,000        
Balance at Mar. 31, 2022 2,077,000 $ 1,931 2,765,503   (689,049) (1,385)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2,285)       (2,285)  
Other comprehensive income (2,955)         (2,955)
Share-based compensation $ 5,973   5,973      
Stock option exercises (in shares) 100,000 114,000        
Stock option exercises $ 1,194 $ 1 1,193      
Equity issuance costs (270)   (270)      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   622,000        
Issuance of common shares in connection with the vesting of restricted stock units $ 0 $ 6 (6)      
Balance (in shares) at Jun. 30, 2022 193,796,000 193,796,000        
Balance at Jun. 30, 2022 $ 2,078,657 $ 1,938 $ 2,772,393   $ (691,334) $ (4,340)